Stocklytics Platform
Asset logo for symbol OPRX
OptimizeRx
OPRX65
$5.21arrow_drop_up7.61%$0.37
Asset logo for symbol OPRX
OPRX65

$5.21

arrow_drop_up7.61%

Income Statement (OPRX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$8.41M-$3.56M-$5.00M--$3.55M
EBITDA-$7.32M-$2.49M-$3.94M--$3.08M
gross Profit$13.44M$11.70M$11.13M$17.84M$9.80M
NET Income-$9.12M-$4.00M-$6.89M-$4.14M-$2.86M
total Revenue$21.30M$18.81M$19.69M$28.36M$16.33M

Balance Sheet (OPRX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt$19.58M$21.12M$21.28M$22.37M-$9.77M
stockholders Equity$114.46M$121.01M$122.53M$126.55M$116.10M
total Assets$165.19M$172.87M$176.36M$183.37M$123.92M
total Debt$35.71M$36.08M$36.46M-$148.64K
total Liabilities$50.73M$51.86M$53.82M$56.82M$7.82M

Cash Flow (OPRX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow-$532.00K-$915.00K-$640.00K$36.18M-$349.42K
free Cash Flow$1.69M$697.00K$1.96M-$5.48M$1.15M
investing Cash Flow-----
operating Cash Flow$1.79M$782.00K$2.11M-$6.25M$1.47M

OptimizeRx (OPRX) Financials

OptimizeRx Corp (OPRX) is a technology company that focuses on providing digital solutions to the healthcare industry. The company offers a platform that enables pharmaceutical companies to communicate directly with healthcare providers, thereby improving the distribution and accessibility of vital information. By leveraging its innovative technology, OptimizeRx Corp aims to streamline the prescription process and enhance patient adherence to medication. As a result, healthcare providers can deliver better patient care and achieve improved health outcomes. With a team of dedicated professionals and a robust technology infrastructure, OptimizeRx Corp is well-positioned to capitalize on the growing demand for digital healthcare solutions.
In terms of financial performance, OptimizeRx Corp has shown consistent growth over the years. The company has reported a steady increase in total revenue, driven by the rising demand for its digital solutions. Additionally, OptimizeRx Corp has been able to maintain a healthy gross profit margin, indicating efficient cost management. The company's net income from stockholders has also shown positive growth, reflecting the success of its business model. Moreover, OptimizeRx Corp's balance sheet remains strong, with a favorable cash position and stockholders equity. This financial stability allows the company to invest in research and development, further enhancing its technological capabilities.
Furthermore, OptimizeRx Corp has a robust cash flow, supported by its strong operating cash flow. This cash flow enables the company to make strategic investments and pursue growth opportunities. OptimizeRx Corp's financing cash flow has also been positive, indicating its ability to raise capital for expansion and acquisitions. Moreover, the company's free cash flow remains healthy, allowing it to generate excess cash that can be used for future investments. Additionally, OptimizeRx Corp's investing cash flow has shown a steady trend, indicating its commitment to enhancing its technological infrastructure and expanding its product offerings.
In summary, OptimizeRx Corp is a technology company that provides digital solutions to the healthcare industry. The company has shown strong financial performance, with consistent revenue growth and a favorable profit margin. Additionally, OptimizeRx Corp's balance sheet remains robust, with a healthy cash position and stockholders equity. The company's cash flow is strong, supported by positive operating and financing cash flows. With its innovative technology and financial stability, OptimizeRx Corp is well-positioned to capitalize on the growing demand for digital healthcare solutions.
add OptimizeRx to watchlist

Keep an eye on OptimizeRx

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level